Gene · 3459
Papers3,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAV1 inhibits Xc- system through IFNGR1 to promote ferroptosis to inhibit stemness and improves anti-PD-1 efficacy in breast cancer. | Transl Oncol | 2024 | 39395272 | PubTator, text mining | PubMed |
| Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10. | Neoplasia | 2024 | 39366148 | PubTator, text mining | PubMed |
| Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin. | Pharmacol Res | 2024 | 39362509 | PubTator, text mining | PubMed |
| Viral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli. | J Clin Invest | 2024 | 39352385 | PubTator, text mining | PubMed |
| Characteristics of Endemic Mycoses Talaromyces marneffei Infection Associated with Inborn Errors of Immunity. | J Clin Immunol | 2024 | 39325235 | PubTator, text mining | PubMed |
| Overexpression of SLC2A1, ALDOC, and PFKFB4 in the glycolysis pathway drives strong drug resistance in 3D HeLa tumor cell spheroids. | Biotechnol J | 2024 | 39295558 | PubTator, text mining | PubMed |
| Branched-chain amino acids supplementation induces insulin resistance and pro-inflammatory macrophage polarization via INFGR1/JAK1/STAT1 signal pathway. | Mol Med | 2024 | 39267003 | PubTator, text mining | PubMed |
| Identification of potential therapeutic targets from bioinformatics analysis of necroptosis and immune infiltration in acute myocardial infarction. | J Cardiothorac Surg | 2024 | 39261934 | PubTator, text mining | PubMed |
| Applying 12 machine learning algorithms and Non-negative Matrix Factorization for robust prediction of lupus nephritis. | Front Immunol | 2024 | 39224582 | PubTator, text mining | PubMed |
| Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer. | Nature | 2024 | 39112706 | PubTator, text mining | PubMed |
| An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification. | Nat Commun | 2024 | 39103360 | PubTator, text mining | PubMed |
| Elevated NS1 serum levels reduce CD119 expression and CXCL-10 synthesis in patients with dengue hemorrhagic fever. | Rev Soc Bras Med Trop | 2024 | 39082520 | PubTator, text mining | PubMed |
| Th1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages. | Mol Med | 2024 | 39080527 | PubTator, text mining | PubMed |
| Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat. | Heliyon | 2024 | 39021957 | PubTator, text mining | PubMed |
| Successful treatment of invasive mycobacterium infection with interferon beta in a patient with Interferon-Gamma Receptor 1 deficiency. | J Infect Public Health | 2024 | 38991411 | PubTator, text mining | PubMed |
| Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles. | Vaccines (Basel) | 2024 | 38932312 | PubTator, text mining | PubMed |
| Lysophosphatidylcholines Promote Influenza Virus Reproduction through the MAPK/JNK Pathway in PMA-Differentiated THP-1 Macrophages. | Int J Mol Sci | 2024 | 38928244 | PubTator, text mining | PubMed |
| Dynamic immune status analysis of peripheral blood mononuclear cells in patients with Klebsiella pneumoniae bloodstream infection sepsis using single-cell RNA sequencing. | Front Immunol | 2024 | 38898888 | PubTator, text mining | PubMed |
| In Vitro Selection of Macrocyclic l-α/d-α/β/γ-Hybrid Peptides Targeting IFN-γ/IFNGR1 Protein-Protein Interaction. | J Am Chem Soc | 2024 | 38888290 | PubTator, text mining | PubMed |
| ExonSurfer: a web-tool to design primers at exon-exon junctions. | BMC Genomics | 2024 | 38867172 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3459/papers?page=8